‘æ18‰ñŽŸ¢‘ã‚ð’S‚¤ŽáŽèˆã—Öò‰ÈŠwƒVƒ“ƒ|ƒWƒEƒ€—DG”­•\Ü  
(‰‰‘è”Ô†‡)  
yŒû“ª”­•\‚Ì•”z

‹ãB‘åŠw‘åŠw‰@ –òŠwŒ¤‹†‰@ –òÜŠw•ª–ì@@¬–“ —TŽi@“a
‰‰@‘èFRNA editing enzyme ADAR2 is involved in P-gp-mediated doxorubicin resistance in murine breast cancer cells via gcircRNA-miRNA pathwayh

•xŽR‘åŠw ŠwpŒ¤‹†•” –òŠwE˜aŠ¿Œn ¶‘Ì–hŒäŠw—Ìˆæ ‚ª‚ñE–Ɖuƒ†ƒjƒbƒg@@”–“c Œ’Žj@“a
‰‰@‘èFGlycolytic Metabolism of CD8+ T cells Affect the Susceptibility to HLA-Mediated Idiosyncratic Drug-induced toxicity

–kŠC“¹‘åŠw‘åŠw‰@ –òŠwŒ¤‹†‰@ –òÜ•ªŽqÝŒvŠwŒ¤‹†Žº@@´… ‚è‚È@“a@
‰‰@‘èFCharacterizing hepatocyte-targeted CRISPR-Cas9 delivery by lipid nanoparticles

ŒF–{‘åŠw‘åŠw‰@–òŠw‹³ˆç•”@@‹ß¼ ãÄ”n@“a@
‰‰@‘èFEnhancement of oral Zn-insulin hypoglycemic effects using a small intestine-permeable cyclic peptide in diabetic mice

‹ãB‘åŠw ‘åŠw‰@–òŠwŒ¤‹†‰@ –ò•¨“®‘ÔŠw•ª–ì@@•Ÿ‰ª q•½@“a@
‰‰@‘èFAnalyzing the effect of vitamin A accumulation on life outcome in chronic kidney disease with a focus on the intestinal microbiota

“Œ‹ž‘åŠwˆãŠw•”•‘®•a‰@ –òÜ•”@@ˆÉ“¡ ŽÑ‘ã@“a@
‰‰@‘èFA proposal for novel drug-drug interaction assessment focused on drug distribution to serum VLDL/LDL

 
 yƒ|ƒXƒ^[”­•\‚Ì•”z

•ŒÉì—Žq‘åŠw –òŠw•” –òÜŠwŒ¤‹†Žº@@è’J ˆ¤–¢@“a
‰‰@‘èFTemperature-responsive Mechanism in Triple-negative Breast Cancer and Development of Novel Therapeutic Strategies

–kŠC“¹‘åŠw ‘åŠw‰@–òŠwŒ¤‹†‰@ —Õ°–òÜŠwŒ¤‹†Žº@@ã“c ˆê“Þ‘¾@“a
‰‰@‘èFContribution of aldehyde oxidase to pharmacokinetics and interindividual differences


‹à‘ò‘åŠw ˆã–ò•ÛŒ’Œ¤‹†ˆæ –òŠwŒn@@âˆä —º‰î@“a
‰‰@‘èFMechanistic analysis of Magenstrasse (stomach road) formation after Meals: Impact on gastric emptying and intestinal absorption of drugs